The newest ad for Whitney Tilson’s Empire Stock Investor ($49, renews at $199) is all about this “Taas” business, and I’ve gotten a few questions since it started circulating a week or two ago… so let’s dig in! The basic idea is that “TaaS,” which is “Transportation as a Service,” is going to take off […]
Sometimes when I’m choosing which ad to cover on a given day it’s based on the number of questions I’ve gotten, or the number of times we’ve seen the ad in the past few days… and sometimes it’s based on something that just feels like something interesting. Today it’s the latter… because Brett Aitken and […]
This article was originally published on January 6, 2020. Neither the ad we’re covering nor this article has been updated since then, though I’ve added a small update note at the end. The stock is back to where it was before the first promo pitch was mailed, and the latest emails pointing to this teaser […]
Yesterday we looked into the first “Hidden SaaS” cloud software stock hinted at in the ads for Stansberry Venture Value, and today, as promised, we’re on to number two… there’s also a third one hinted at, but the clues are pretty sparse on that one (so no promises). Let’s just jump right in — what […]
I’ve gotten a bunch of questions about the latest teasers for Stansberry Venture Value (“on sale” for $1,897/yr, no refunds), so I thought I’d dig into that a little bit today — they’re hinting at a couple cloud SaaS stocks to pique your interest… and, well, consider me piqued. The ad is not brand new, […]
Whitney Tilson has a new teaser pitch out for his entry-level newsletter… the bait to pull you in to read the ad is “America’s #1 Retirement Stock,” and then he also hints at the other four components of the “perfect portfolio” … so I thought I’d dig into that for you and see what we […]
Entry level newsletter from Tilson/Stansberry’s Empire Financial Research, plans to recommend one large cap US stock per month for 3-5 year holding periods.
Dave Lashmet has been a biotech/medical analyst and sometimes a newsletter editor at Stansberry for a long time, and the latest iteration of his high-end newsletter is now called Stansberry Venture Technology (currently “on sale” for $2,500, no refunds)… and it’s now being promoted with a “cure for cancer” spiel, so we obviously all want […]
Over the weekend I got a lot of questions about John Engel’s “Image Mapping” pitch for his Stansberry Innovations Report newsletter ($49, renews at $199), so that’s what we’re tasking the Thinkolator with today… what is this “Image Mapping” technology that he says will make us 5X our money? Stansberry Innovations Report is quite new, […]
Monthly entry-level newsletter designed to “help you understand and take advantage of the world’s most promising investments in the energy and natural resources space.” Shaw also edits Stansberry’s Gold & Silver Investor.
Apparently, Stansberry True Wealth editor Steve Sjuggerud recommended a gold stock at the Stansberry conference this week, and it was teased in the Stansberry Digest emails that a bunch of readers sent to me this morning… so that’s our quickie topic of the day. Here’s how that stock was teased to non-attendees: “Longtime Digest readers […]
Stansberry is launching a new high-end data-powered service in partnership with Joel Litman, and I’ve gotten quite a few questions about their first round of promos… so although I’m sure I can’t dig into the accounting as well as Litman, I’ll at least try to figure out which individual stock they’re teasing in these ads […]
Monthly newsletter providing small-cap stock recommendations aimed at individual investors, recommendations are based on “hidden value” he sees using the UAFRS accounting adjustments developed by his Valens Research company for institutional subscribers.
Stansberry Research Dan Ferris says a rare low risk $13 Gold Stock could be a 20 bagger. Any ideas on this one?
This is not the kind of ad I love to cover, mostly because it takes me out of my comfort zone into an area where my knowledge is very limited, but we’re getting tons of questions about the Crypto Capital pitch from Stansberry and the huge 1,000% gains promoted because of this September 12 event… […]
New cryptocurrency-focused newsletter launched by Stansberry Research in 2019 (with a brief period as a publication from Stansberry Pacific before that), aims to identify lesser-known cryptocurrency tokens for trading and investment.
Monthly service that suggests discounted corporate bonds.
We’re seeing a lot of questions this week about the promo from Stansberry for Dan Ferris’ Extreme Value (currently $1,499, no refunds), so that’s our focus for today. And it looks like this is a repeat of an ad we’ve looked at a couple times over the past 18 months, but it’s got a new […]
So I’m sure many of you have heard Stansberry pounding the drum that they are joining with Jim Rogers to predict the next CRASH. They went all in, as this time the push was advertised on CNBC, XM Radio and more. They promised to give the ”best bear market stock to own” for free at […]
Seems like old news on China. Any validity to what is being pitched?
Options trading course.
The latest ad pitch from the Stansberry folks, a marketing letter/presentation that’s urging you to subscribe to Stansberry Innovations Report ($49/yr at the moment), tells us that… “This Tiny Firm Could Tip the Scales in… The Battle to Save the Internet” So you can leave your subtlety by the back door today. What is this […]
We were going back and forth if its smart to bite The Melt-Up portfolio bait. So fellow #GumshoeCommunity, did you sign up? How are the returns over the past few tumultuous months?
New (2018) entry level newsletter from Stansberry, features several special reports on big technology themes.
The latest email ad from Stansberry Research entices us into believing that Stansberry’s got the next gargantuan gainer, like Amazon or Apple… “Nearly two decades ago, one of our analysts covered an obscure online bookstore called Amazon… “And it went on to change how we shop forever. “Today it’s one of the biggest companies on […]
This article was first published in late February, and was lightly updated in April, the last time the ad ran heavily — and now the ad is circulating again in mid-August, so I’ve made some slight updates again. What follows is mostly unchanged from 2/28. The price of the stock is also again close to […]
The ads that get the most attention tend to be either those that are most dramatically distributed, with seemingly every single email address getting multiple copies… or those that come with a big promise and a very high price. Today’s topic of interest is the latter, since we’re told that Stansberry Venture Value’s Dave Lashmet […]
The talk of “Trade War” is everywhere in the financial media, as you’ve no doubt seen — the first round of “tit for tat” trade tariffs has been decided on both sides, with the US planning tariffs against Chinese steel and aluminum and the Chinese retaliating with tariffs on a variety of mostly agricultural products […]
Here’s the headline of the latest ad from the Casey Research folks… “The One Step the President Must Take to Push the Dow Jones to 50,000 – and GUARANTEE He Wins the Next Election. “This is the Start of the Last Bull Market of Your Life and a Massive Opportunity to Get Rich Before it’s […]
I’ve had a couple readers ask about this one, and it seems fairly interesting, so I thought I’d look into it even though it doesn’t seem to have been particularly actively promoted. The “tease” came in Steve Sjuggerud’s free Daily Wealth newsletter over the weekend, as bait to tempt subscribers into his True Wealth newsletter […]
Lots and lots and lots of you have been asking me about the big “cancer presentation” that the Stansberry folks made last night, which apparently was a combination of Dr. David Eifrig’s medical advice and forecasting and Dave Lashmet’s hinting about his “medical breakthrough” stock… so let’s get to it. I did not watch or […]
I like the work of Dan Ferris, I’ve seen him present at a few conferences over the years, and have read plenty of his free commentaries (and teaser ads), and his ideas, while not particularly sexy, are well-researched and interesting. That doesn’t mean they’re always successful, of course — I’ve written about several stocks he […]
Today I’m looking for the first time at a teaser ad from Bill Shaw, who is the Senior Analyst for Stansberry’s precious metals service — that service is now called Stansberry Gold & Silver Investor, and it’s one of the “no refunds, get a portfolio all at once” services that Stansberry has been pushing lately. […]
Brett Eversole has a new ad letter out promoting subscriptions to True Wealth, Steve Sjuggerud’s “entry level” newsletter service over at Stansberry, and it sounds awfully exciting — how do we make 500% returns, and what’s the “tiny device that’s eating the world?” Well, the ad is all about mobile payments — using your cell […]
A Porter Stansberry newsletter about speculation, where they “attempt to profit from market extremes”.
I’m a little late getting going today… I’d like to say that I’m jet-lagged, but really I’m just email-lagged as I try to dig through the few days of messages that I missed in my brief foray to the Emerald Isle over the past few days (which was fantastic, by the way, thanks for asking). […]
Let’s start with a little exercise… this is the pivotal sentiment of the latest pitch from Chris Wood in his ad for Casey’s Extraordinary Technology newsletter: “The Stock Story I’m About To Share With You Is The BIGGEST Of My Entire Career” How often, do you imagine, is something similar said in an ad for […]
Quite a few eagle-eyed Gumshoe readers forwarded the latest ad from Dr. David Eifrig to us over the weekend — he’s pitching his Retirement Millionaire newsletter, which is an “entry level” offering from Stansberry that includes money-saving retirement tips and health tips as well as investment ideas. It tends to not be an aggressive or […]
High cost newsletter launched early in 2017, focused on identifying “10X” stocks that are small but have great capital efficiency and potential for very high long-term returns. Originally sold as part of a $7,999 lifetime package (plus $299/year renewal fee) with Dave Lashmet’s Stansberry Venture Technology, then was quiet for a while but was later […]
China-focused stock advisory launched late Summer 2016, initially aimed to profit from Chinese internet stocks that they thought had the potential to rise more rapidly than their US counterparts. Uses different subscription model ($2.000 nonrefundable fee, then $149/yr. for as long as you want to keep getting updates).
This ad has been rolling for a week or so, and a group of Gumshoe readers have already been discussing it and trying to figure out exactly what the Stansberry folks are talking about… but there are lots of questions still coming over the transom here at Castle Gumshoe, so let’s take a look. The […]
Nick Giambruno is helming the Crisis Investing letter for Casey Research now, which must come with a fairly high degree of attention because Doug Casey really made his name with his bestselling book of the same name in the late 1970s (later revised a couple times). And after all this time you know what you’re […]
Dave Lashmet has teased a handful of biotech stocks since starting the Stansberry Venture service a couple years ago, and they usually get a lot of attention from our readers — so the new ad from Lashmet today has been forwarded to me dozens of times already. And while I’m not sure we’ll be able […]
Porter Stansberry’s 2016-launched push for gold, which he thinks could hit $10,000 — differently structured newsletter, with a $1,750 up front charge for the full portfolio report and then $49 a month for portfolio updates.
I’ve got a few stocks to mention in the medical space this week — one to update that’s in my portfolio, one to confirm as a teaser pick (since folks keep asking) after several Gumshoe readers discussed it last week, and one to note as a teaser idea that’s being pushed pretty heavily (though the […]
How about something on Stansberry’s latest – “Pinpoint Surgery” stock?
We’ve been on strange schedules here in Gumshoeland for the last two weeks, and during that time we’ve seen a large number of quarterly reports come through that deserve some attention or comment… as well as a few other notable news items that I feel like I should pay attention to. And, of course, we’ve […]
A quickie for the gold enthusiasts to discuss today, since several folks have asked about this “special gold fund” in the last week. And yes, it’s not a super-hard one… but it’s pretty timely, and I thought it might be worth batting it around a bit. Here’s the snippet from Stansberry that I got from […]
The following was originally published on November 10 and has not been updated or revised. The teaser ad covered is being circulated again today with a slightly different headline pitch about cellphone royalties, but the balance of the ad (and the teased company) are largely unchanged. —from 11/10/14— Dr. David Eifrig is touting something that […]
We’ve got a good teaser to solve today, but first — a quick plea: This will be our final week of “Gumshoe Gives Back” this year — we will be donating at least half of all the membership contributions received through the rest of this week (until the end of the day on Friday, 12/12) […]
Monthly small-cap investing newsletter that aims to have a “venture capital” investing mindset, looking for high-risk opportunities for dramatic gains, primarily in tech or biotech.
Immunotherapy for cancer has been in the news quite a bit in recent years, with several drugs making an impact on the worst cancers and giving some real hope for future advancement — not a small thing for a basic medical strategy that’s been tested and tweaked for 125 years now by folks following in […]
I hate to continue to write about this small company with great frequency, since it smacks of “talking my book” (it’s a major personal holding), but we have received a lot of questions from readers today about Dan Ferris’ latest pitch, so we’re re-running our previous free article about this one. Last time around, it […]
Famous families and historical fortunes fascinate investors — the idea that these families you know and (sometimes) worship created vast fortune because of one wily speculator way back in the family tree is almost irresistibly interesting. It gives us the feeling that any family can rise up and make a big bet on the way […]
It’s like the Stansberry folks know what appeals to your friendly neighborhood Stock Gumshoe… and they just can’t get enough of our coverage. Every time I turn around lately they’re teasing and promoting a different kind of “royalty” company. And I loves me some royalties. Royalty companies are pretty well understood by most investors — […]
There have been two pretty big promo campaigns about the Alibaba IPO in the last week or so — one from Bill Patalon in an ad for his Private Briefing, and the other from Mike Palmer for Jeff Clark’s S&A Short Report… so I thought we should try to take a look, answer some reader […]
Today we have to put my usual cautionary note up top. The stock Frank Curzio is pitching as the key supplier for “The 20-Second Battery” is ridiculously small. It has already been recommended to his subscribers over at Phase 1 Investor, so presumably they’ve gotten their fill of the stock (he also touted it about […]
These are my notes and instant reactions from a presentation at the Value Investing Congress, the notes below might contain errors, paraphrases, incorrect quotes, or misinterpretations. Dan Ferris, who we have covered many times, is presenting about Altius Minerals (ALS.TO, ATUSF), which he has covered for years and we’ve written about many times (it’s also […]
Several intrepid readers sent this pitch flying my way while we were digging out of our latest snowstorm, and I figured a nice little panic about an $82 billion “missed opportunity” ought to warm me up. Phase 1 Investor, the big “upgrade” letter from Stansberry & Associates, usually gets our readers attention when they send […]
OK, so this one’s a bit tricky. And not just because the clues are a bit limited. Don’t worry, we’ll still find an answer for you … but a caveat or two first … Frank Curzio edits Phase 1 Investor, which is Stansberry’s “big ticket” newsletter that typically covers small tech, biotech and natural resources […]
Buy this ‘Under $0.50’ Stock by November 1st, 2013 “This is one of the few times in the history of our business we have recommended a company so small and with such high upside potential. A triple-digit gain within the next 12-36 months is highly possible…. “We’ve been vetting the opportunity for nearly two years.” […]
Premium addition to the free DailyWealth newsletter, with options and other trading recommendations issued on a daily basis.
Premium-priced options trading service, seems to be built on using “blue chip” stocks for the underlying investment idea and selling puts for income on those stocks while using some of that cash to buy calls for upside leverage.
Trading research service focused on Jeff Clark’s options trading strategy.
This is all going to sound at least somewhat familiar — the Stansberry folks are sending around a teaser ad that cites Hillary Clinton’s huge non-government earnings on her tax returns, and tells us that through the miracle of “Mainz Income” we can all make money using this same technique. It’s familiar because it’s been […]
Well, well, well — another month, another Phase 1 teaser from Frank Curzio and the Stansberry folks. And if you’re going to use your massive mailing list of a few million investors to sell a $3,000 newsletter that most of them won’t ever consider, well, you can pretty much predict that the queries will make […]
Here’s the lead-in to the new Stansberry & Associates pitch: “How I Got My Multi-Millionaire Grandmother To Finally ‘Spill The Beans’ On Her BIG Retirement Secret “She went from making $17 a week… to completely retired, practically overnight. She hasn’t worked a day in over 53 years and will NEVER outlive her money. “She’s never […]
Phase 1 Investor is the big kahuna newsletter at Stansberry & Associates, the $5,000 newsletter that they typically discount to $3,000 when sending out promo emails … … and they market this letter so heavily that Gumshoe readers flood our inbox whenever a new Phase 1 teaser ad runs. So … another of their teasers […]
I know that many of you have seen the teasers for the “$1.10 a Day Retirement Plan” that are being sent around the interwebs by the folks at the 12% Letter — not many folks have the email marketing might of Stansberry & Associates, that letter’s publisher, and lots of you have been asking about […]
Today we’re looking at something that several readers have asked me about, but that I haven’t seen pushed all that actively by a hyperactive teaser. Don’t worry, we won’t completely avoid hyperbole … they always sneak it in somewhere. But this pitch is for a stock being recommended by Steve Sjuggerud for his True Wealth […]
Steve Sjuggerud just started teasing a new website that he’s launched called valuableproperties.com — which apparently is an add-on to his True Wealth newsletter, at least for now (one presumes that if it’s a big hit, they’ll come up with a way to charge more for it). The ad is posed as an “interview” with […]
I guess we should really be calling this “A.O.P. 2.0”, since the Stansberry folks used this same basic marketing pitch on investors about five years ago — though I think that was in service of their S&A Resource Report (then called the S&A Oil Report), and this one is an ad for the relatively conservative, […]
Water always gets quite a bit of attention around Gumshoe Headquarters — it is a perennial topic of investor interest, and we see waves of excitement about water stocks rise and fall with some regularity. And it’s not hard to see why — fresh, clean water is in short supply in much of the world […]
“The last time this happened, early investors had an opportunity to make a fortune. Now one team of researchers thinks it’s happening again… with an unusual, little-known mining stock.” That’s the opening of the latest teaser from Frank Curzio for his Phase 1 Investor newsletter, and it’s not the first time we’ve heard the promise […]
Huh? Are the Canadian Maple Leaf silver coins going to suddenly become twice as valuable as the American Eagle silver coins? No, don’t worry, it’s not that simple and silver is still fungible, an ounce is an ounce is an ounce (well, a troy ounce, anyway). So what’s the idea of “Canadian silver” being somehow […]
It’s probably no surprise that the Stansberry & Associates newsletters probably get more attention from Stock Gumshoe than most of the others — they’re right up there with the Motley Fool when it comes to the size of their mailing lists and the response from our readers to their promos, so everything they do and […]
I had another note in mind to share with you today, but the overwhelming demand for answers about the new Phase 1 promo that started mailing last night has jumped it to the top of my inbox. Frank Curzio’s Phase 1 Investor newsletter, which is the pricey letter published by Stansberry ($5,000, but usually “on […]
This teaser is going to get a lot of attention from Gumshoe readers, partly because Stansberry Phase 1 Investor teasers always get a lot of attention (they usually tease a small stock and they charge $5,000 for the newsletter, which gives them an aura of awesomeness — deserved or not), and partly because the pitch […]
Monthly newsletter highlighting technology and biotech stocks, previously edited by Alex Daley.
This teaser has gotten a lot of attention from my readers, as do all the pitches thrown by the folks at Stansberry’s Phase 1 Investor newsletter — you just know that if you charge $5,000 for a subscription, and use one of the world’s largest investor mailing lists to tease a tiny stock in order […]
I’ve been blathering about my own investments in these Friday Files for a couple weeks now, but for today we’re going back to sniffing out teaser picks … in this case, a teaser pick for “Gold Fracking” that Frank Curzio has been sending out pretty aggressively for a couple days in pitches for his Small Stock […]
Matt Badiali edits the S&A Resource Report, which is an “entry level” (ie, less than $100 a year) newsletter that’s currently “on sale” for $39, and his latest pitch for new members has caught the attention of many of the folks in Gumshoe Nation. He’s pitching something he calls “Secret Gold Societies” … and if […]
I don’t often cover the same editor or pundit twice in a row, but it’s not exactly a hard rule … which is a relief, because the most interesting thing I came across this morning was another teaser from Dan Ferris. Now, it’s not the same hard sell as his 12% Letter pitch that we […]
We haven’t covered the 12% Letter in these pages for a few months, if memory serves, so I was pleased to get several questions from readers about their latest teaser for the “secret retirement legacy” that’s apparently been offered up by George Bush (the dumber one, not the older one). Did I just type that […]
We’ve now reached a groundswell of eager reader questions about Steve Sjuggerud’s “Treasury Rights” teaser, so let’s dig in and have a look. Steve’s letter tells us that this is “the most realistic way to make outrageous ‘once-in-a-lifetime’ gains today” … a very tantalizing promise indeed. And of course, for the full information about these […]
Steve Sjuggerud is teasing us with something genuinely compelling as he urges us to subscribe to his True Wealth newsletter: investments that NEVER go down. Really? Yep, his pitch is that he has three kinds of investments that, if taken together, can be considered to be a “mutual fund” that never goes down. They’re not […]
Over the last several months we’ve seen several ads touting Steve Sjuggerud’s True Wealth Systems, which is apparently a big quantitative screening “supercomputer” that Steve subcontracted to some computer programmers — and which is supposed to identify investing anomalies that he can then write about to his subscribers, who then will profit. And I can’t […]
Investment recommendations generated by quantitative data-crunching system that looks for “anomalies.”
Small cap resource stock picking letter, mostly Canadian juniors.
Active trading newsletter, tends to focus on income and options trades.
I suppose I should expect this by now — whenever Frank Curzio and the gang put out a teaser for Phase 1 Investor, which is the big-money newsletter from Stansberry & Associates ($5,000/year, though almost always “on sale” at $3,000 when they’re running promos), my inbox gushes like Spindletop. Didn’t matter if it was a […]
This story has been making the rounds for quite a while — and in different versions, I’ve written about essentially this same pitch before … but it’s been years since it really hit the Gumshoe radar, and folks keep asking, so I thought I’d check out this latest version of the ad for you. The […]
OK, you can stop asking now — because we’re just about to finish up with our latest multi-part series, covering the “loopholes” from the “Black Market Income” teaser for Stansberry’s 12% Letter. This letter pitches the idea that they have a secret website that “Wall Street” doesn’t want you to see — all about how […]
A couple variations on this teaser about “black market income” have been rolling around the marketplace for months now — the actual investments are still relatively normal, mainstream-ish companies and strategies, just as they were when the 12% Letter called parts of this “black market income” strategy by other names, which is why I haven’t […]
You can always count on a good story from a Phase 1 teaser — Phase 1 is the fancy top-of-the-line upgrade newsletter from Stansberry & Associates ($5,000/year, though it’s usually “on sale” for $3,000 when they’re promoting it as they are now), currently edited by Frank Curzio, and it has historically focused on lots of […]
Mike Williams, who edits the True Income newsletter from Stansberry & Associates, has been trying to get new subscribers by promising to reveal the secrets of the “32% clause” that can pay you a huge annual income stream. So what on earth is he talking about? Here’s how the ad begins: “Introducing: A completely legal […]
Frank Curzio is tantalizing us to subscribe to his Penny Stock Specialist newsletter (Stansberry & Assoc.) by teasing about a few penny stocks in the shale gas business — but of course, that’s not enough, there has to be a huge back story as well. And the story this time, should you choose to sit […]
Today I’m sniffing out a solution to a teaser that is just a couple sentences long — not really a “hyped to the moon” stock like so many I write about, but one that sounded interesting to me (and to enough of my readers that the questions are piling up a little bit). It’s from […]
How can you find sacks of treasure located around 776 cities around the country? That’s the pitch from Retirement Millionaire from Stansberry & Associates — the ad, which is one of those good ol’ video ads that doesn’t happen to link to a text version, even includes a “treasure map” of those cities around the […]
After several years of touting (and sometimes teasing) microcap mining stocks for subscribers of Stansberry’s super-expensive Phase 1 newsletter, Matt Badiali is launching a new letter that focuses on these small stocks, picks that he says are too small and volatile for his inexpensive S&A Resource Report letter. This letter is called the S&A Junior […]
Those who’ve been with the Gumshoe for a while know that it’s tough to top Stansberry’s Phase 1 Investor for marketing that uses over-the-top hyperbole about tiny biotech and mining stocks, and creative names that obscure the truth behind their investments — that doesn’t seem to have changed much with the new(ish) guy at the […]
Today’s tease didn’t come to me directly and I haven’t seen the original ad or letter where it appeared, but this excerpt was forwarded by a large number of folks who appear to have some interest in a good ‘ol blue chip-type investment. The tease must have been in some kind of subscribers-only letter for […]
I always like to see what Dan Ferris is recommending for subscribers of his Extreme Value newsletter, in part because I’m personally invested in a few of his picks that have done well (Altius Minerals and Sprott Resource), and in part because I’m generally sympathetic to the notion that long-term “value” investing is the best […]
I’ve been saving this one for the Friday File, since it’s one of several similar stocks I’ve been thinking about for my own account — though I haven’t invested in the company as of now (and won’t for at least three days, per my rules). The teaser came from the same ad as the SVB […]
I’ve been getting lots of questions about this secret toll-free phone number this week, so I thought I should try to take a look for you today. Apparently it’s all about some way to boost your dividend by calling a special phone number — which can’t help but conjure up a mental image of vast […]
Well, someone on the forum just this morning asked if we could “stick a pin in this balloon” … and I’m happy to oblige. The “Penny Bonds” teaser is in an ad for True Income, a newsletter from Mike Williams over at Stansberry & Associates, and it’s all about how these investments can be “more […]
Well, it’s been a long time since I’ve written about this particular investment newsletter from the Stansberry folks, so I thought I should take a look for all the new people we have on board here at Stock Gumshoe over the last six months … and to see if he’s changing up his strategy at […]
This article is an excerpt from the May 21 Friday File (the extra commentary that paid members of this site receive) — but I’m still getting a lot of questions about Dan Ferris and his farming stock, so what follows is the part of that note regarding the teased agriculture company. I have not updated […]
Well, it didn’t take long for Porter Stansberry to get his newest analyst, Frank Curzio, to headline the Phase 1 Investor newsletter, their most expensive product — this is a letter that has focused mostly on biotech, other tiny tech stocks, and junior miners over the last couple years that I’ve written about them (at […]
There’s a small stack of potential teasers just sitting and waiting for the attention of the Thinkolator, but your friendly neighborhood Gumshoe is but a humble servant to the masses of the assembled Gumshoe faithful … so when I start getting hundreds of questions about one specific teaser, that moves to the top of the […]
Well, the folks at Stansberry are now releasing the penny stock newsletter that they’ve been testing for a few months — and of course, they’d like you to subscribe. The editor is Frank Curzio, who used to run a similar newsletter at TheStreet.com focusing on stocks under $10. So just as a warning, both Curzio […]
Monthly small cap newsletter, formerly called Penny Stock Specialist. Canceled when Curzio left Stansberry.
Coverage of retirement issues, discounts and deals, and investment strategies and concepts. Not focused solely on being an investment-picking letter but does make recommendations.
I was puttering around this morning, trying to decide what to share with my favorite folks, the Irregulars today … when I got a question from the very newest Irregular, and decided that her teasers sounded pretty interesting. This new reader (welcome, D.C.!) sent me a teaser I hadn’t seen yet, for Braden Copeland and […]
Weekly trading service focused on tiny companies.
Weekly trading service that follows insider buying trends to make recommendations, often shorter-term trades.
I’m sure a great many of you have received the ad for Porter Stansberry’s Inside Strategist newsletter — it’s all about a California tech company that’s going to release news on Tuesday next week, and that Porter thinks could jump by 50% if they release the news he expects (or drop like a stone, of […]
Focuses on small, potentially explosive growth companies, mostly in mining, tech and biotech. Formerly run by Rob Fannon. Stopped publishing after Curzio left Stansberry, Stansberry now Publishes the similar Stansberry Venture as their high-priced letter.
Options-based service that aims for steady income, generally by selling covered calls but also using other strategies. No longer exists as of our last check in 2017 and Jeff Clark appears not to be working for Stansberry any longer, though Dr. David Eifrig’s Retirement Trader from the same publisher sometimes uses similar options income strategies.
Recommends trades (long and short) based on clinical trials, particularly for smaller pharmaceutical and biotech companies.
Quite a number of you have sent notes to me about these, um, notes lately — if you’re on many of the newsletter or financial mailing lists you’ve probably seen them, too. This is a teaser that promises … “Buy this investment today and “lock in” a minimum gain of 244% (It could possibly even […]
Many of the delightful readers of Gumshoe Nation have sent in this ad, for the True Income service from Stansberry & Associates. As with so many ads these days, it teases us that, (if we’ll just subscribe and follow their advice), we can make tremendous profits with lower risk. Here’s how it opens: “Can “Mega-Bond” […]
Newsletter that recommends bond investments, particularly high yield corporate bonds.
Service that recommends selling puts against “absurdly cheap” stocks.
Stansberry & Associates’ Phase 1 Investor newsletter is teasing us about shares of a drug company: “On March 30, FDA results we’ve waited 2 years to receive could make you $195,600, overnight” — and they quote Porter Stansberry as saying that “This is the kind of situation that can change your life… where a $10,000 stake can allow you to literally quit work, forever.” Sounds nice, eh?
Monthly newsletter that focuses on high-dividend stocks and similar investments. (Formerly edited by Tom Dyson, who left to found the Palm Beach Letter publications with Mark Ford) This letter was merged into Stansberry’s Income Intelligence letter, edited by Dr. David Eifrig.
This newsletter focuses on commodity-related stocks, including other natural resources beyond just oil. Edited by Matt Badiali for many years before being taken over by Flavious Smith in 2017.
Free daily newsletter from a variety of contributors, mostly editors of S&A newsletters.
Weekly trading service that recommends aggressive short term moves, often with options.
Monthly newsletter that recommends “deep value” stocks.
Monthly newsletter recommends undervalued, “blue chip” and “next boom” stocks.
Monthly newsletter aims to find undervalued, unloved or contrarian investments.
Phew, just when you think things are slowing down for the summer … out comes a new concept in Gumshoe teaserdom. Porter Stansberry’s folks are launching a new service, called True Income, which invests in something a little bit different … something that they’re teasing as “finally, a safe alternative to stocks!” The service is […]
Whatever they’re paying the copywriters at Stansberry & Associates, it’s not enough. This stuff is pure gold! Drive-Thru Retirement … now that’s a good idea. I’ll take the Super Size Value Combo, please! The latest ad from S&A is for a new service they’re providing, a monthly dividend tracking system of some kind, which essentially […]
The Tom Dyson 801(k) teaser letter for Stansberry and Associates’ 12% Letter must be one of the more successful email campaigns out there — at least, if the interest of my readers is any indication. I’ve probably had more questions about this than any other email teaser I’ve ever written about. I first wrote about […]